6 UK Stocks Make March Best Ideas List

Morningstar equity analysts have compiled a list of the best value stocks across the globe. Six UK listed stocks make the cut

Alex Morozov, CFA 1 March, 2018 | 10:04AM
Facebook Twitter LinkedIn

pharmaceutical company laboratory healthcare cancer drug

Reckitt Benckiser (RB.)

We are adding RB, formerly known as Reckitt Benckiser, to the Best Ideas list because we think its wide moat and above-average pricing power are underappreciated. RB's fourth-quarter results show that the company is not immune from the ongoing structural changes in consumer staples retail; however, with a portfolio that is increasingly skewed to businesses with pricing power, we think RB has a better chance than most in its peer group of reigniting organic growth.

The near term may remain ugly due to the return of commodity inflation, the recovering British pound, and pricing pressures in the weaker parts of the portfolio, but if the firm can return to a long-term organic revenue growth rate of closer to 5% while sustaining its margins, we believe there will be significant upside to the stock.

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
BT Group PLC139.55 GBX1.86Rating
Imperial Brands PLC1,578.50 GBX1.32Rating
Reckitt Benckiser Group PLC5,426.00 GBX0.65Rating
WPP PLC978.80 GBX-1.31Rating

About Author

Alex Morozov, CFA  Alex Morozov is the director of the health-care team at Morningstar.